Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 5,040,000 | 4,920,000 | 4,854,000 | 4,885,000 | 4,523,000 |
| Cost of Goods | 1,402,000 | 1,361,000 | 1,305,000 | 1,307,000 | 1,191,000 |
| Gross Profit | 3,638,000 | 3,559,000 | 3,549,000 | 3,578,000 | 3,332,000 |
| Operating Expenses | 2,120,000 | 2,241,000 | 2,073,000 | 2,259,000 | 1,986,000 |
| Operating Income | 1,518,000 | 1,318,000 | 1,476,000 | 1,319,000 | 1,346,000 |
| Other Income | 0 | 0 | 0 | -853,000 | 0 |
| Pre-tax Income | 1,518,000 | 1,318,000 | 1,476,000 | 466,000 | 1,346,000 |
| Income Tax | 421,000 | 366,000 | 410,000 | 53,000 | 380,000 |
| Net Income Continuous | 1,097,000 | 952,000 | 1,066,000 | 413,000 | 966,000 |
| Net Income | $1,097,000 | $952,000 | $1,066,000 | $413,000 | $966,000 |
| EPS Basic Total Ops | 0.55 | 0.48 | 0.54 | 0.21 | 0.48 |
| EPS Basic Continuous Ops | 0.55 | 0.48 | 0.54 | 0.21 | 0.49 |
| EPS Diluted Total Ops | 0.54 | 0.47 | 0.53 | 0.21 | 0.47 |
| EPS Diluted Continuous Ops | 0.54 | 0.47 | 0.53 | 0.20 | 0.48 |
| EBITDA(a) | $1,676,000 | $1,482,000 | $1,643,000 | $1,487,000 | $1,502,000 |